欧洲联盟的法院

Informed Choices in Cross-Border Enforcement Pub Date : 2021-01-15 DOI:10.1017/9781839701306.008

V. V. D. Eeckhout

{"title":"欧洲联盟的法院","authors":"V. V. D. Eeckhout","doi":"10.1017/9781839701306.008","DOIUrl":null,"url":null,"abstract":"Competition — Agreements, decisions and concerted practices — Pharmaceutical products — Market for antidepressants (citalopram) — Settlement agreements relating to disputes concerning process patents concluded by a manufacturer of originator medicines who holder of those patents and manufacturers of generic medicines — Article 101 TFEU — Potential competition — Restriction by","PeriodicalId":151025,"journal":{"name":"Informed Choices in Cross-Border Enforcement","volume":"63 1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Court of Justice of the European Union\",\"authors\":\"V. V. D. Eeckhout\",\"doi\":\"10.1017/9781839701306.008\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Competition — Agreements, decisions and concerted practices — Pharmaceutical products — Market for antidepressants (citalopram) — Settlement agreements relating to disputes concerning process patents concluded by a manufacturer of originator medicines who holder of those patents and manufacturers of generic medicines — Article 101 TFEU — Potential competition — Restriction by\",\"PeriodicalId\":151025,\"journal\":{\"name\":\"Informed Choices in Cross-Border Enforcement\",\"volume\":\"63 1 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-01-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Informed Choices in Cross-Border Enforcement\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1017/9781839701306.008\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Informed Choices in Cross-Border Enforcement","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1017/9781839701306.008","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

竞争-协议、决定和协调一致的做法-药品-抗抑郁药(西酞普兰)市场-与专利持有人的原药制造商和仿制药制造商签订的工艺专利纠纷有关的解决协议- TFEU第101条-潜在竞争-限制

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

The Court of Justice of the European Union

Competition — Agreements, decisions and concerted practices — Pharmaceutical products — Market for antidepressants (citalopram) — Settlement agreements relating to disputes concerning process patents concluded by a manufacturer of originator medicines who holder of those patents and manufacturers of generic medicines — Article 101 TFEU — Potential competition — Restriction by

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Informed Choices in Cross-Border Enforcement

自引率

0.00%

发文量